Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders

SAN DIEGO & OSAKA, Japan–(BUSINESS WIRE)–Neurocrine Biosciences and Takeda announced a strategic collaboration for compounds in Takeda’s early-to-mid-stage psychiatry pipeline.